Readily Available Index of Insulin Sensitivity Is Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes
<b>Background/Objectives</b>: Insulin resistance is a key factor in the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD), but accurately measuring it in patients with type 2 diabetes (T2D) remains challenging. This study examines the relatio...
Saved in:
| Main Authors: | Stefano Ciardullo, Alessandro Roberto Dodesini, Emanuele Muraca, Pietro Invernizzi, Roberto Trevisan, Gianluca Perseghin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Diabetology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-4540/6/6/50 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Type 2 Diabetes Mellitus
by: Hilmi Erdem Sümbül, et al.
Published: (2025-03-01) -
A prospective study on the role of non-invasive tests in the evaluation of diabetes mellitus associated steatotic liver disease
by: Zülal İstemihan, et al.
Published: (2025-07-01) -
An Assessment of the Feasibility, Patient Acceptance, and Performance of Point-of-Care Transient Elastography for Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review and Meta-Analysis
by: Taranika Sarkar Das, et al.
Published: (2024-11-01) -
Liver stiffness and serum galectin 3 level significantly increases in patients with prediabetes: a fibroscan study
by: Huseyin Ali Ozturk, et al.
Published: (2025-04-01) -
Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience
by: Thanikan Sukaram, et al.
Published: (2025-01-01)